{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:01:36Z","timestamp":1789038096374,"version":"build-2803163510"},"reference-count":37,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"unspecified","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100003185","name":"National Psoriasis Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100003185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022606","name":"Almirall","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100022606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023331","name":"LEO Pharma","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100023331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Life expectancy of patients with psoriasis is reduced by 4\u20135 years due to cardiovascular disease with an increased risk of myocardial infarction at an earlier age compared with the general population. This increased risk is independent of traditional cardiovascular risk factors and higher in moderate-to-severe forms of psoriasis. Inflammation may play a key role in the development of atherosclerosis in these patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>A prospective cohort study, Early Detection and Progression of Subclinical Atherosclerosis in Psoriasis (EDSAP), was initiated in January 2020 to investigate the presence and progression of subclinical atherosclerosis in patients with psoriasis. 120 patients aged 30\u201365 years and eligible for biological treatment have been recruited at Hospital Ram\u00f3n y Cajal in Madrid, Spain. Patients undergo a baseline visit, and 1-year follow-up visit after starting biological therapy. Each visit includes: assessment of cardiovascular risk factors, screening for subclinical atherosclerosis by two-dimensional\/three-dimensional ultrasound of carotid and femoral arteries, cardiac CT of coronary arteries and blood sampling. All baseline visits were completed by December 2022, and the remaining follow-up visits will be concluded by the end of 2023. The EDSAP study aims to identify new molecular and imaging markers associated with the presence of atherosclerosis and its progression in a chronic inflammatory state such as psoriasis. This has the potential to: (1) help improve primary cardiovascular prevention strategies in these patients; (2) understand the effect of biological drugs on the cardiovascular system; and (3) serve as a model for understanding atherosclerosis in other chronic inflammatory diseases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>The study protocol has been approved by the Institutional Review Board of the Hospital Ram\u00f3n y Cajal in Madrid. We will present our findings at national and international congresses, and peer-reviewed journals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial Registration number<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05858099\">NCT05858099<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2023-072455","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T17:11:02Z","timestamp":1695748262000},"page":"e072455","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Early Detection and Progression of Subclinical Atherosclerosis in Psoriasis (EDSAP): protocol for an observational, single-centre, prospective cohort study"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct05858099","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Carlota","family":"Abbad-Jaime de Arag\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Berna-Rico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Asunci\u00f3n","family":"Ballester-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Ja\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Sol\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda G","family":"Barderas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Fern\u00e1ndez-Friera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal","family":"N Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M","family":"Gelfand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8060-4784","authenticated-orcid":false,"given":"\u00c1lvaro","family":"Gonz\u00e1lez-Cantero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,9,26]]},"reference":[{"key":"2023102420252460000_13.9.e072455.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61128-3"},{"key":"2023102420252460000_13.9.e072455.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.08.040"},{"key":"2023102420252460000_13.9.e072455.3","unstructured":"JAMA Network . Risk of myocardial infarction in patients With psoriasis | acute coronary syndromes, Available: https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/203598 [Accessed 30 Nov 2022]."},{"key":"2023102420252460000_13.9.e072455.4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.026859"},{"key":"2023102420252460000_13.9.e072455.5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/ATVBAHA.118.312246","article-title":"Inflammasome signaling and impaired vascular health in psoriasis","volume":"39","author":"Garshick","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023102420252460000_13.9.e072455.6","unstructured":"PubMed . Potential immunological links between psoriasis and cardiovascular disease. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/29910818\/ [Accessed 6 Dec 2022]."},{"key":"2023102420252460000_13.9.e072455.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.05.016"},{"key":"2023102420252460000_13.9.e072455.8","doi-asserted-by":"crossref","unstructured":"Berna-Rico E , Abbad-Jaime de Aragon C , Garcia-Aparicio A , et al . Cardiovascular screening practices and Statin prescription habits in patients with psoriasis among dermatologists, rheumatologists and primary care physicians. Acta Derm Venereol 2023;103:5087. doi:10.2340\/actadv.v103.5087","DOI":"10.2340\/actadv.v103.5087"},{"key":"2023102420252460000_13.9.e072455.9","doi-asserted-by":"crossref","unstructured":"Gonzalez-Cantero A , Gonzalez-Cantero J , Sanchez-Moya AI , et al . Subclinical atherosclerosis in psoriasis. usefulness of femoral artery ultrasound for the diagnosis, and analysis of its relationship with insulin resistance. PLoS One 2019;14:e0211808. doi:10.1371\/journal.pone.0211808","DOI":"10.1371\/journal.pone.0211808"},{"key":"2023102420252460000_13.9.e072455.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2011.11.025"},{"key":"2023102420252460000_13.9.e072455.11","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/jamadermatol.2016.2907","article-title":"Comparison of coronary artery calcium scores between patients with psoriasis and type 2 diabetes","volume":"152","author":"Mansouri","year":"2016","journal-title":"JAMA Dermatol"},{"key":"2023102420252460000_13.9.e072455.12","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.amjmed.2015.05.041","article-title":"Increased prevalence of coronary artery disease in severe psoriasis and severe atopic dermatitis","volume":"128","author":"Hjuler","year":"2015","journal-title":"Am J Med"},{"key":"2023102420252460000_13.9.e072455.13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/joim.13311","article-title":"Prevalence and severity of coronary artery disease linked to prognosis in psoriasis and Psoriatic arthritis patients: a multi-centre cohort study","volume":"290","author":"Tinggaard","year":"2021","journal-title":"J Intern Med"},{"key":"2023102420252460000_13.9.e072455.14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.014310"},{"key":"2023102420252460000_13.9.e072455.15","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jaad.2018.07.007","article-title":"Femoral artery ultrasound for improving the detection of atherosclerosis in psoriasis","volume":"80","author":"Gonz\u00e1lez-Cantero","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2023102420252460000_13.9.e072455.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.05.033"},{"key":"2023102420252460000_13.9.e072455.17","doi-asserted-by":"crossref","unstructured":"Kaur S , Kingo K , Zilmer M . Psoriasis and cardiovascular risk\u2014do promising new biomarkers have clinical impact? Mediators Inflamm 2017;2017:7279818. doi:10.1155\/2017\/7279818","DOI":"10.1155\/2017\/7279818"},{"key":"2023102420252460000_13.9.e072455.18","unstructured":"European Heart Journal Oxford Academic . ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk, . 2019 Available: https:\/\/academic.oup.com\/eurheartj\/article\/41\/1\/111\/5556353"},{"key":"2023102420252460000_13.9.e072455.19","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/cvr\/cvz009","article-title":"Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study","volume":"115","author":"Elnabawi","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2023102420252460000_13.9.e072455.20","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jcmg.2022.01.005","article-title":"New 3-dimensional volumetric ultrasound method for accurate quantification of Atherosclerotic plaque volume","volume":"15","author":"L\u00f3pez-Melgar","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023102420252460000_13.9.e072455.21","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1093\/eurheartj\/ehy645","article-title":"Emerging applications of coronary CT angiography in coronary heart disease: getting better with time","volume":"39","author":"Elnabawi","year":"2018","journal-title":"Eur Heart J"},{"key":"2023102420252460000_13.9.e072455.22","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1001\/jamadermatol.2016.1984","article-title":"Association between changes in coronary artery disease progression and treatment with biologic agents for severe psoriasis","volume":"152","author":"Hjuler","year":"2016","journal-title":"JAMA Dermatol"},{"key":"2023102420252460000_13.9.e072455.23","doi-asserted-by":"crossref","unstructured":"Hu SCS , Lan CCE . Psoriasis and cardiovascular comorbidities: focusing on severe vascular events, cardiovascular risk factors and implications for treatment. Int J Mol Sci 2017;18:2211. doi:10.3390\/ijms18102211","DOI":"10.3390\/ijms18102211"},{"key":"2023102420252460000_13.9.e072455.24","first-page":"1388","article-title":"Primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"379","author":"Mart\u00ednez-Gonz\u00e1lez","year":"2018","journal-title":"N Engl J Med"},{"key":"2023102420252460000_13.9.e072455.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1994.tb01167.x"},{"key":"2023102420252460000_13.9.e072455.26","doi-asserted-by":"publisher","DOI":"10.1159\/000081812"},{"key":"2023102420252460000_13.9.e072455.27","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.14140611"},{"key":"2023102420252460000_13.9.e072455.28","doi-asserted-by":"crossref","unstructured":"Sorokin AV , Patel N , Abdelrahman KM , et al . Complex association of apolipoprotein E-containing HDL with coronary artery disease burden in cardiovascular disease. JCI Insight 2022;7:e159577. doi:10.1172\/jci.insight.159577","DOI":"10.1172\/jci.insight.159577"},{"key":"2023102420252460000_13.9.e072455.29","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M700239-MCP200"},{"key":"2023102420252460000_13.9.e072455.30","doi-asserted-by":"publisher","DOI":"10.1021\/pr800362h"},{"key":"2023102420252460000_13.9.e072455.31","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M115.055905"},{"key":"2023102420252460000_13.9.e072455.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2013.03.041"},{"key":"2023102420252460000_13.9.e072455.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2014.07.013"},{"key":"2023102420252460000_13.9.e072455.34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/eurjpc\/zwaa033","article-title":"Underperformance of clinical risk scores in identifying imaging-based high cardiovascular risk in psoriasis: results from two observational cohorts","volume":"29","author":"Gonzalez-Cantero","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2023102420252460000_13.9.e072455.35","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1016\/j.jid.2021.03.024","article-title":"Impact of biological agents on imaging and biomarkers of cardiovascular disease in patients with psoriasis: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"141","author":"Gonz\u00e1lez-Cantero","year":"2021","journal-title":"J Invest Dermatol"},{"key":"2023102420252460000_13.9.e072455.36","doi-asserted-by":"crossref","unstructured":"Kaiser H , Wang X , Kvist-Hansen A , et al . Biomarkers of subclinical atherosclerosis in patients with psoriasis. Sci Rep 2021;11:21438. doi:10.1038\/s41598-021-00999-9","DOI":"10.1038\/s41598-021-00999-9"},{"key":"2023102420252460000_13.9.e072455.37","doi-asserted-by":"crossref","first-page":"681172","DOI":"10.3389\/fmed.2021.681172","article-title":"Psoriasis to psoriatic arthritis: the application of proteomics technologies","volume":"8","author":"Qi","year":"2021","journal-title":"Front Med"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-072455","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T03:26:14Z","timestamp":1698204374000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-072455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":37,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9,26]]},"published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1136\/bmjopen-2023-072455"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-072455","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}